These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25775909)

  • 1. [Effectiveness of pharmacotherapy of irritated bowel syndrome from the standpoint of evidence based medicine].
    Sheptulin AA; Vize-Khripunova MA
    Klin Med (Mosk); 2014; 92(7):64-8. PubMed ID: 25775909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End points in irritable bowel syndrome.
    Mangel AW; Fehnel SE
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):293-5. PubMed ID: 21651345
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Gale JD
    Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
    Shah E; Kim S; Chong K; Lembo A; Pimentel M
    Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern Management of Irritable Bowel Syndrome: More Than Motility.
    Tack J; Vanuytsel T; Corsetti M
    Dig Dis; 2016; 34(5):566-73. PubMed ID: 27331917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for Irritable Bowel Syndrome.
    Med Lett Drugs Ther; 2020 Mar; 62(1594):25-32. PubMed ID: 32324172
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment experience of patients with irritable bowel syndrome complicated by constipations with medicinal preparation softovak].
    Ruchkina IN; Lychkova AE; Parfenov AI
    Eksp Klin Gastroenterol; 2007; (5):103-6. PubMed ID: 18389606
    [No Abstract]   [Full Text] [Related]  

  • 8. Board Review Vignette: Irritable Bowel Syndrome.
    Talley NJ
    Am J Gastroenterol; 2016 Sep; 111(9):1223-5. PubMed ID: 27527743
    [No Abstract]   [Full Text] [Related]  

  • 9. American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome.
    Chang L; Lembo A; Sultan S
    Gastroenterology; 2014 Nov; 147(5):1149-72.e2. PubMed ID: 25224525
    [No Abstract]   [Full Text] [Related]  

  • 10. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linaclotide, novel therapy for the treatment of chronic idiopathic constipation and constipation-predominant irritable bowel syndrome.
    Vazquez-Roque MI; Bouras EP
    Adv Ther; 2013 Mar; 30(3):203-11. PubMed ID: 23436110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?
    Tack J
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome.
    Weinberg DS; Smalley W; Heidelbaugh JJ; Sultan S;
    Gastroenterology; 2014 Nov; 147(5):1146-8. PubMed ID: 25224526
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
    Camilleri M
    Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey.
    Rangan V; Ballou S; Shin A; Camilleri M; ; Lembo A
    Gastroenterology; 2020 Feb; 158(3):786-788.e1. PubMed ID: 31711922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical Evaluation and Management of Irritable Bowel Syndrome with Diarrhea: A Case Study Approach.
    Lacy BE
    J Fam Pract; 2018 Aug; 67(8 suppl):S31-S36. PubMed ID: 30137051
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-based medicine in practice: applying intention-to-treat analysis and perprotocol analysis.
    Schoenfeld PS
    Am J Gastroenterol; 2005 Jan; 100(1):3-4. PubMed ID: 15654771
    [No Abstract]   [Full Text] [Related]  

  • 18. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):53-4. PubMed ID: 18617872
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics).
    Khalif IL; Quigley EM; Makarchuk PA; Golovenko OV; Podmarenkova LF; Dzhanayev YA
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):17-22. PubMed ID: 19337628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.